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Case 2
Her mother; 46 year-old, was invited to our 
Rheumatology outpatient unit. She had chief 
complains of skin thickening on the face and the 
upper trunk since six months prior to that visit. 
Her fi ngers also changed color when they exposed 
to cold however she could not recall when it 
started. She had suffered from cough, fever, 
and fatigue for the last two weeks prior to visit 
Rheumatology Unit. She lives in the same house 
with her own daughter. Physical examination 
revealed sclerodactily, “salt and pepper” 
appearance in the posterior of the neck and upper 
trunk and the skin tautness with the Rodnan skin 
score of 19. On lung examinations, fine crackles 
were noticed from both lower lungs. Cardiac and 
abdominal examinations were normal. Laboratory 
studies revealed a leukocyte count of 5,230/
mm3, hemoglobin of 13.5g/dl, platelet count of 
32.7x104 mm3, and ESR 28mm/h. Urinalysis 
detected microscopic hematuria and leukocyturia 
without proteinuria and with a Ccr of 117.4 ml/
min. Acid-fast bacteria from sputum examination 
was negative. Other laboratory values were CRP 
8.1mg/ml, Complement C3 0.97 g/L, and C4 0.11 g/
L. The RF level was 64 (positive). Anti SS-A, anti 
SS-B, anti Scl-70, anti dsDNA were all negative. 
Anti nRNP/Sm and anti CENP B were positive 
with high titer (positive +++). Anti Ro-52 and anti 
Sm were also positive. ANA was 14.55 (N<1). 
Chest X-ray revealed minimal infi ltrates at both 
lungs. Electrocardiogram and echocardiogram 
were all normal. In a barium enema study of the 
esophagus, no delay was observed. She was also 
diagnosed as SSc with diffuse cutaneous type. 
DISCUSSION
Antibody and genetic factor
Systemic sclerosis is uncommon connective tissue 
disease and its etiology is unknown. The genetic 
of SSc are complex, and the disease is believed not 
inherited in a straightforward mendelian fashion. 
Twins show a low rate of disease concordance 
(<5%).2 The concordance of scleroderma in twins is 
5.9%, roughly 300-fold that of chance alone.3 This 
rate is similar between monozygotic and dizygotic 
twin pairs. However, one recent study analyzing 
the prevalence of the disease among monozygotic 
and dizygotic twin pairs revealed a quite low 
and similar concordance rate among identical 
and fraternal twins (about 4.7%), arguing for a 
Systemic sclerosis (SSc) is uncommon connective 
tissue disease characterized by a pathological 
thickening and tethering of the skin and involvement 
of internal organ (i.e gastrointestinal tract, heart, 
lungs, and kidneys). Systemic sclerosis seems to 
result from a multifactorial process (alteration of 
the immune system, genetic, and environmental 
factors) but its pathogenesis remains unclear. A 
familial history of SSc represents an important 
risk factor for developing the disease.1 We describe 
two generations family who developed SSc.
CASE REPORT
Case 1
A 25 year old female visited Rheumatology out-
patient units at Cipto Mangunkusumo Hospital, 
Jakarta with the chief complain of fi ngers turn 
blue when they are exposed to cold temperature, 
since three months prior to this visit.  She also 
had swollen hands, fatigue, and arthralgias. 
Physical examination showed blood pressure 
of 90/70 mmHg, a regular heart beat of 84/min, 
and a temperature of 35.8°C, sclerotic plaque 
with macular hyperpigmentation in the scalp, 
pre-auricular, and anterior of the neck, and some 
teleangiectasias at the tip of the fi ngers. Her skin 
showed taut at face, hands, fi ngers, and feet, with 
the Rodnan skin score of 10. Cardiopulmonary 
examinations were within normal limit. 
Laboratory studies revealed a leukocyte count of 
6.320/mm3, hemoglobin of 14.1g/dl, platelet count 
of 398x103mm3, and erythrocyte sedimentation 
rate (ESR) of 6 mm/h. Ureum 20/mm3 and serum 
creatinine 0.5/mm3 with a creatinine clearance 
rate (Ccr) of 102.2 ml/min (Cockroft-Gault 
formula). Urinalysis and electrolytes were normal. 
Other laboratory values were CRP 0.2mg/ml, 
Rheumatoid factor (RF) <8 (negative), antinuclear 
antibodies (ANA) test 14.32 (N <1), ANA profi le 
showed positive Anti Scl-70 (+++), the others 
were negative. She underwent biopsy of the skin 
and the histopathology showed scleroderma (see 
fi gure 1). The electrocardiogram and chest X-ray 
were normal. She was diagnosed with diffuse 
cutaneous SSc based on New York criteria for the 
SSc. She was started with nifedipine 5 mg b.i.d, 
and methotrexate 7.5 mg/week, and folic acid. 
Interestingly, she informed that her mother has the 
same problem with her.
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shared environmental rather than a genetic link.4 Other studies 
have shown that SSc occurs signifi cantly more frequently in 
families with SSc (1.6%) than in general population (0.026%). 
Although the absolute risk of SSc for each family member 
is low, a positive family history represents the strongest risk 
factor yet identifi ed for SSc, indicating an important role for 
heredity in disease susceptibility. First-degree relatives of SSc 
patients also are more likely to have a positive antinuclear 
antibody than controls.5 However, there is not an increased 
familial occurrence of more specifi c serologic features such as 
serum anticentromere antibody.6
 In contrast to other connective tissue diseases, HLA 
linkages are generally weak in SSc. Particular HLA haplotypes 
do show associations with distinct serologically defi ned SSc 
subsets, however. A cluster of SSc cases had been described 
among Choctaw Native Americans living in Oklahoma, with 
affected individuals sharing a unique American Indian HLA 
haplotype (B35, Cw4, DRB1*1602[DR2], DQA1*0501, 
and DQB1*0301 [DQ7]).4,6 Report from Asia showed that 
DRB1*0101, *0405, and *1302 alleles were associated 
with high anticentromere antibody titers in the Japanese 
population.7 
Figure 1   Skin biopsy of patient 1 (above) and patient 2 (below). Dermis 
consists of fi ber tissue with parallel bundle showing paucity of skin 
adnexal glands.
 Current investigations in SSc genetics focus primarily on 
polymorphisms in candidate genes. Associations of specifi c 
single nucleotide polymorphism have been reported in genes 
involved in immunity and infl ammation, vascular function, 
and connective tissue homeostasis.
 Signifi cant serologic heterogeneity is well known to 
occur in SSc. Although it remains controversial whether 
autoantibodies seen in patients with SSc have an actual role 
in pathogenesis, these serologic markers are useful in the 
diagnosis and clinical management of scleroderma patients. 
Anti-U1-RNP antibodies are usually seen in association with 
CTD overlaps, specifi cally with Raynaud’s phenomenon, 
joint involvement, myositis, lcSSc, and a more favorable 
outcome.8
 The antibodies of our patients showed positive result 
for the ANA and other autoantibodies, shown on table 1. 
This was similar to the previous report of increased familial 
autoimmune responses. However there were no data of the 
HLA of our patients, due to lack of fund. 
 Systemic sclerosis seems to result from a multifactorial 
process. Many studies reporting familial aggregation have been 
published.3,5 The implication of genetic factors is supported 
by other evidence, for example, the increased prevalence of 
autoimmune responses (ANA) and other autoimmune diseases 
in relatives of patients with SSc and a higher incidence of 
some genetic polymorphisms and HLA associations.
Table 1   Autoantibodies of two patients
 Autoantibodies Patient 1 Patient 2
ANA  14.32 14.55
Anti-nRNP/Sm (-) (+++)
Anti-Sm  (-) (+)
Anti SS-A  (-) (-)
Anti-Ro-52  (-) (++)
Anti SS-B  (-) (-)
Anti-Scl-70  (+++) (-)
Anti-CENP B (-) (+++)
Anti ds-DNA (-) (-)
Anti-Rib.P-Protein (-) (-)
Clinical manifestation
Raynaud’s phenomenon used to be described as initial 
complaint in approximately 70% of patients with SSc.4 Both 
of our patients also have Raynaud’s phenomenon as the 
initial complaint. Both of the patients were diagnosed to have 
diffuse type cutaneous SSc, base on the skin involvement. 
The mother had lung involvement which might be part of 
the manifestation of SSc. Further investigation such as high 
resolution CT scan should be done to evaluate the fi brosis 
in the lung, this will determine the prognosis and also the 
decision to treat more aggressively with the cytostatic agent 
(cyclophosphamid) for better outcome.9 There are several 
reports of familial scleroderma, further research is needed to 
reveal possible genetic predisposition to the disease, especially 
in Asian Country.
SUMMARY
We have reported two cases of SSc in two generations: a 
mother and her offspring. Genetic and autoantibodies showed 
important role in the case of SSc. 
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